Healthcare provider profile · identity verified

Daniel Keith Paulson, MD

Family Practice · SPRINGFIELD, OR · NPI 1578530341

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	595	159
Lisinopril	Lisinopril	366	103
Amlodipine Besylate	Amlodipine Besylate	268	78
Omeprazole	Omeprazole	262	61
Metformin Hcl	Metformin Hcl	247	62
Levothyroxine Sodium	Levothyroxine Sodium	197	51
Losartan Potassium	Losartan Potassium	189	51
Albuterol Sulfate Hfa	Albuterol Sulfate	170	53
Rosuvastatin Calcium	Rosuvastatin Calcium	160	45
Hydrochlorothiazide	Hydrochlorothiazide	155	44
Metoprolol Tartrate	Metoprolol Tartrate	151	43
Gabapentin	Gabapentin	145	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	139	26
Furosemide	Furosemide	138	38
Tamsulosin Hcl	Tamsulosin Hcl	134	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	124	32
Carvedilol	Carvedilol	108	31
Sertraline Hcl	Sertraline Hcl	103	30
Potassium Chloride	Potassium Chloride	100	27
Eliquis	Apixaban	93	27
Metoprolol Succinate	Metoprolol Succinate	91	26
Tramadol Hcl	Tramadol Hcl	91	17
Metformin Hcl Er	Metformin Hcl	89	21
Pantoprazole Sodium	Pantoprazole Sodium	84	20
Warfarin Sodium	Warfarin Sodium	82	19
Pravastatin Sodium	Pravastatin Sodium	80	18
Simvastatin	Simvastatin	75	21
Trazodone Hcl	Trazodone Hcl	72	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	18
Trulicity	Dulaglutide	66	13
Oxycodone Hcl	Oxycodone Hcl	63	12
Tizanidine Hcl	Tizanidine Hcl	59	15
Escitalopram Oxalate	Escitalopram Oxalate	55	11
Fluoxetine Hcl	Fluoxetine Hcl	55	17
Jardiance	Empagliflozin	55	15
Spironolactone	Spironolactone	55	15
Montelukast Sodium	Montelukast Sodium	53	11
Allopurinol	Allopurinol	52	15
Alendronate Sodium	Alendronate Sodium	49	suppressed
Lorazepam	Lorazepam	48	suppressed
Prednisone	Prednisone	48	31
Duloxetine Hcl	Duloxetine Hcl	47	14
Clopidogrel	Clopidogrel Bisulfate	44	11
Pregabalin	Pregabalin	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	41	13
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	15
Glimepiride	Glimepiride	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Citalopram Hbr	Citalopram Hydrobromide	38	11
Naproxen	Naproxen	38	suppressed
Glipizide	Glipizide	37	12
Meloxicam	Meloxicam	36	11
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Lovastatin	Lovastatin	33	suppressed
Ondansetron Odt	Ondansetron	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	25
Propranolol Hcl	Propranolol Hcl	32	suppressed
Irbesartan	Irbesartan	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Alprazolam	Alprazolam	28	suppressed
Torsemide	Torsemide	28	suppressed
Incruse Ellipta	Umeclidinium Bromide	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Famotidine	Famotidine	24	suppressed
Lactulose	Lactulose	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	12
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Acyclovir	Acyclovir	23	suppressed
Atenolol	Atenolol	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Ozempic	Semaglutide	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	12
Finasteride	Finasteride	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Testosterone Cypionate	Testosterone Cypionate	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Cimetidine	Cimetidine	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Nystatin	Nystatin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Diazepam	Diazepam	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Estradiol	Estradiol	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Risperidone	Risperidone	16	suppressed
Alyacen	Norethindrone-Ethin. Estradiol	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Amoxicillin	Amoxicillin	14	13
Bumetanide	Bumetanide	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Xtampza Er	Oxycodone Myristate	14	suppressed
Baclofen	Baclofen	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tacrolimus	Tacrolimus	13	suppressed
Temazepam	Temazepam	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Cephalexin	Cephalexin	12	11
Indapamide	Indapamide	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error